Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
Clinical trial NCT02956473 · COMPLETED
Trial details
- NCT number
- NCT02956473
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2022-08-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.